Income Before Tax
Pre-Tax Income
Revolution Medicines, Inc. Pre-Tax Income decreased by 24.4% to -$453.82M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 112.6%, from -$213.42M to -$453.82M. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income shows a downward trend with a 56.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionIncome Before Tax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026
How to read this metric
Higher values indicate stronger overall profitability and operational efficiency before tax impacts.
Detailed definition
Measures the profitability of the company after all operating and non-operating expenses have been deducted, but before...
Peer comparison
A standard GAAP metric used universally to compare pre-tax performance across different industries.
Metric ID:
income_before_taxHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$44.30M | -$52.94M | -$52.68M | -$57.65M | -$61.22M | -$73.63M | -$56.63M | -$68.10M | -$98.30M | -$112.30M | -$161.19M | -$116.00M | -$133.23M | -$156.29M | -$195.32M | -$213.42M | -$247.79M | -$305.21M | -$364.89M | -$453.82M |
| QoQ Change | — | -19.5% | +0.5% | -9.4% | -6.2% | -20.3% | +23.1% | -20.3% | -44.3% | -14.2% | -43.5% | +28.0% | -14.9% | -17.3% | -25.0% | -9.3% | -16.1% | -23.2% | -19.6% | -24.4% |
| YoY Change | — | — | — | — | -38.2% | -39.1% | -7.5% | -18.1% | -60.6% | -52.5% | -184.6% | -70.3% | -35.5% | -39.2% | -21.2% | -84.0% | -86.0% | -95.3% | -86.8% | -112.6% |
Range-$453.82M – -$44.30M
CAGR+63.2%
Avg YoY Growth-64.5%
Median YoY Growth-56.5%
Current Streak8 quarters decline
Pre-Tax Income at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s pre-tax income?
- Revolution Medicines, Inc. (RVMD) reported pre-tax income of -$453.82M in Q1 2026.
- How has Revolution Medicines, Inc.'s pre-tax income changed year-over-year?
- Revolution Medicines, Inc.'s pre-tax income decreased by 112.6% year-over-year, from -$213.42M to -$453.82M.
- What is the long-term trend for Revolution Medicines, Inc.'s pre-tax income?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s pre-tax income has grown at a 56.8% compound annual growth rate (CAGR), from -$187.09M to -$1.13B.
- What does pre-tax income mean?
- Total profit earned before accounting for income tax obligations.